SEMINOMA
Clinical trials for SEMINOMA explained in plain language.
Never miss a new study
Get alerted when new SEMINOMA trials appear
Sign up with your email to follow new studies for SEMINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy duo takes on rare tumors in nationwide trial
Disease control OngoingThis phase 2 trial tests whether combining two immunotherapy drugs, nivolumab and ipilimumab, can shrink tumors in adults with rare cancers. About 818 participants with over 50 different rare tumor types receive the drugs to see how many respond. The goal is to control the diseas…
Matched conditions: SEMINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 01, 2026 17:42 UTC
-
New study aims to lower relapse risk in testicular cancer patients
Disease control OngoingThis study compares two chemotherapy treatments for men with stage I seminoma testicular cancer who have risk factors for relapse. Participants receive either one course of carboplatin (standard care) or a stronger combination of three drugs (BEP). The goal is to see if BEP leads…
Matched conditions: SEMINOMA
Phase: PHASE3 • Sponsor: St. Olavs Hospital • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
New hope for incurable germ cell tumors? drug trial targets stubborn cancers
Disease control OngoingThis study tests the drug cabozantinib in 50 adults with germ cell tumors (testicular, ovarian, or related cancers) that have not responded to standard chemotherapy. The goal is to see if the drug can shrink tumors or stop them from growing for at least 3 months. Participants wil…
Matched conditions: SEMINOMA
Phase: PHASE2 • Sponsor: Jennifer King • Aim: Disease control
Last updated May 01, 2026 15:58 UTC